Clinical Research Directory
Browse clinical research sites, groups, and studies.
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
Sponsor: ARQ National Psychotrauma Centre
Summary
This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.
Official title: High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-05-16
Completion Date
2027-01
Last Updated
2025-07-24
Healthy Volunteers
No
Conditions
Interventions
High-intensity inpatient MDMA-assisted psychotherapy
Drug: 3,4-methylenedioxymethamphetamine (MDMA) Session 1: 80 mg MDMA HCl followed by a supplemental dose of 40 mg Session 2: 120 mg MDMA HCl followed by a supplemental dose of 60 mg Psychotherapy: manualized psychotherapy
Locations (1)
ARQ National Psychotrauma Centre / ARQ Centrum'45
Oegstgeest, Netherlands